We are live on ! Find out more
DMKJ

David M. Knott Jr Portfolio holdings

AUM $189M Turnover 22.11%
1-Year Est. Return 67.72%
This Fund
S&P 500
This Quarter Est. Return
+20.64%
1 Year Est. Return
+67.72%
3 Year Est. Return
+169.37%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$265M
AUM Growth
+$27M
Cap. Flow
-$19.1M
Cap. Flow %
-7.21%
Top 10 Hldgs %
60.48%
Holding
196
New
11
Increased
11
Reduced
19
Closed
23
Avg Time Held Equity + Options
0.7 years
Top 10 Avg Time Held Equity + Options
0.8 years
Top 20 Avg Time Held Equity + Options
0.7 years
Avg Time Held Equity only
0.7 years
Top 10 Avg Time Held Equity only
0.9 years
Top 20 Avg Time Held Equity only
0.7 years

Top Buys

Rank Stock Value
1
OABI icon
OmniAb
OABI
+$6.67M
2
CSX icon
CSX Corp
CSX
+$2.11M
3
CLMT icon
Calumet Specialty Products
CLMT
+$1.85M
4
SNY icon
Sanofi
SNY
+$1.58M
5
ARDX icon
Ardelyx
ARDX
+$1.44M

Top Sells

Rank Stock Value
1
LGND icon
Ligand Pharmaceuticals
LGND
+$4.51M
2
EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
+$3.08M
3
GLHAW
Glass Houses Acquisition Corp. Warrant
GLHAW
+$2.88M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$2.74M
5
PFE icon
Pfizer
PFE
+$2.35M

Sector Composition

Rank Sector Weight
1 Materials 29.69%
2 Healthcare 28.82%
3 Financials 9.61%
4 Miscellaneous 8.4%
5 Consumer Staples 6.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
CLMT icon
1
Calumet Specialty Products
CLMT
$5.06B
$74.9M 28.32%
4,440,000
+115,000
+3% +$1.85M
2021 Q4
4 quarters
APO icon
2
Apollo Global Management
APO
$67B
$14.4M 5.42%
225,000
– –
2021 Q4
4 quarters
MDLZ icon
3
Mondelez International
MDLZ
$79.9B
$14M 5.29%
14,000
– –
2021 Q4
4 quarters
FBRT icon
4
Franklin BSP Realty Trust
FBRT
$500M
$11.1M 4.19%
859,047
– –
2021 Q4
4 quarters
GOOG icon
5
Alphabet (Google) Class C
GOOG
$4.2T
$9.96M 3.76%
112,220
– –
2021 Q4
4 quarters
DCGO icon
6
DocGo
DCGO
$26.9M
$9.9M 3.74%
1,400,000
– –
2021 Q4
4 quarters
LGND icon
7
Ligand Pharmaceuticals
LGND
$5.88B
$7.68M 2.9%
115,000
-69,345
-38% -$4.51M
2021 Q4
4 quarters
FTAI icon
8
FTAI Aviation
FTAI
$16.8B
$7.28M 2.75%
425,000
– –
2021 Q4
4 quarters
MITAW icon
9
DELISTED
Coliseum Acquisition Corp. Warrant
MITAW
$5.69M 2.15%
495,000
– –
2021 Q4
4 quarters
AGAC.WS
10
DELISTED
African Gold Acquisition Corp Warrants
AGAC.WS
$5.18M 1.96%
450,750
– –
2021 Q4
4 quarters
MDWT
11
DELISTED
Midwest Holding Inc. Common Stock
MDWT
$4.97M 1.88%
390,241
– –
2021 Q4
4 quarters
PFE icon
12
Pfizer
PFE
$166B
$4.84M 1.83%
94,500
-49,000
-34% -$2.35M
2021 Q4
4 quarters
HZNP
13
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$4.61M 1.74%
40,490
-3,000
-7% -$249K
2021 Q4
4 quarters
OABI icon
14
OmniAb
OABI
$662M
$4.58M 1.73%
+1,270,939
New +$6.67M
2022 Q4
0 quarters
JNJ icon
15
Johnson & Johnson
JNJ
$612B
$4.38M 1.66%
24,800
– –
2021 Q4
4 quarters
ARDX icon
16
Ardelyx
ARDX
$824M
$4.28M 1.62%
1,500,000
+850,000
+131% +$1.44M
2022 Q3
1 quarter
VKTX icon
17
Viking Therapeutics
VKTX
$3.24B
$3.59M 1.36%
381,621
+79,818
+26% +$356K
2021 Q4
4 quarters
JAZZ icon
18
Jazz Pharmaceuticals
JAZZ
$13.6B
$3.57M 1.35%
22,411
– –
2021 Q4
4 quarters
CTIC
19
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$3.41M 1.29%
566,687
– –
2021 Q4
4 quarters
KW icon
20
DELISTED
Kennedy-Wilson Holdings
KW
$2.75M 1.04%
175,000
– –
2021 Q4
4 quarters
JPM icon
21
JPMorgan Chase
JPM
$890B
$2.73M 1.03%
20,385
– –
2021 Q4
4 quarters
MRK icon
22
Merck
MRK
$364B
$2.72M 1.03%
24,500
– –
2021 Q4
4 quarters
SNY icon
23
Sanofi
SNY
$95.3B
$2.71M 1.02%
56,000
+36,000
+180% +$1.58M
2022 Q3
1 quarter
XENE icon
24
Xenon Pharmaceuticals
XENE
$3.28B
$2.35M 0.89%
59,500
– –
2021 Q4
4 quarters
MDGL icon
25
Madrigal Pharmaceuticals
MDGL
$10.6B
$2.32M 0.88%
8,000
+7,000
+700% +$685K
2022 Q3
1 quarter
1
2 3 4 5

Similar funds

SCA
Sander Capital Advisors Seattle, Washington $189M AUM 13.06% 1-Year Est. Return
FI
FWG Investments Lexington, Kentucky $189M AUM 18.47% 1-Year Est. Return
MFS
Madrid Financial Services Manhattan Beach, California $189M AUM 30.12% 1-Year Est. Return
FRA
FFG Retirement Advisors Centennial, Colorado $189M AUM 16.39% 1-Year Est. Return
CAM
Councilmark Asset Management Knoxville, Tennessee $189M AUM 26.93% 1-Year Est. Return
BAG
Bauman Advisory Group Las Vegas, Nevada $189M AUM
SHC
SALT Holding Corp Wilmington, Delaware $189M AUM 34.63% 1-Year Est. Return
HC
Hara Capital Bellevue, Washington $190M AUM 42.56% 1-Year Est. Return

David M. Knott Jr's Q4 2022 Portfolio in Review

As of Q4 2022, David M. Knott Jr held 196 positions worth $265M, up 11% from $238M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

David M. Knott Jr withdrew a net $19.1M in Q4 2022, closing 23 positions and reducing 19 holdings. Its most notable exit was Eiger BioPharmaceuticals, Inc., an estimated $3.08M position sold in full.

By sector, the portfolio is most concentrated in Materials at 30% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.

Against the trend, David M. Knott Jr opened a new position in OmniAb worth $4.58M.

  • David M. Knott Jr's largest Q4 2022 buy was OmniAb: 1,270,939 shares worth $4.58M.
  • David M. Knott Jr added most to Calumet Specialty Products in Q4 2022, an estimated $1.85M increase.
  • David M. Knott Jr's biggest Q4 2022 reduction was Ligand Pharmaceuticals, cutting an estimated $4.51M.
  • David M. Knott Jr fully exited Eiger BioPharmaceuticals, Inc. in Q4 2022, selling an estimated $3.08M.
  • David M. Knott Jr's ten largest holdings make up 60% of its $265M portfolio in Q4 2022.
  • David M. Knott Jr opened 11 new positions and closed 23 in Q4 2022.
  • David M. Knott Jr's portfolio value rose 11% quarter-over-quarter to $265M.

Based on David M. Knott Jr's 13F filing for Q4 2022, filed 13 Feb 2023.